Newsroom
Sorted by: Latest
-
Carnegie Mellon University und Cleveland Clinic entwickeln KI-System für die präzisere Interpretation von MRT-Aufnahmen des Herzens
PITTSBURGH & CLEVELAND--(BUSINESS WIRE)--Ein Forscherteam der Carnegie Mellon University hat in Zusammenarbeit mit dem Cardiovascular Innovation Research Center der Cleveland Clinic ein System künstlicher Intelligenz (KI) entwickelt, das in der Lage ist, einige der komplexesten medizinischen Aufnahmen des Herzens, kardiale Magnetresonanztomographie (MRT), zu interpretieren, ohne dass manuell gekennzeichnete Trainingsdaten erforderlich wären. Das neue System CMR-CLIP interpretiert MRT-Aufnahmen...
-
L'université Carnegie Mellon et la Cleveland Clinic développent un système d'IA dédié à une interprétation encore plus précise des IRM cardiaques
PITTSBURGH et CLEVELAND--(BUSINESS WIRE)--Une équipe de chercheurs de l'université Carnegie Mellon , en collaboration avec le le Centre de recherche sur l'innovation cardiovasculaire de la Cleveland Clinic, a développé un système d'intelligence artificielle (IA) capable d'interpréter certains des examens cardiaques les plus complexes en médecine, comme l'imagerie par résonance magnétique (IRM) cardiaque, sans nécessiter de données d'apprentissage étiquetées manuellement. Ce nouveau système, bap...
-
MSCI Announces Dates for 2026 Annual Market Classification and Accessibility Reviews
NEW YORK--(BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today that it will release the results of the MSCI 2026 Global Market Accessibility Review on June 18, 2026, and the results of the MSCI 2026 Annual Market Classification Review on June 23, 2026. Both announcements will be made available shortly after 10:30 p.m. Central European Summer Time (CEST) on www.msci.com/market-classificati...
-
FCPT Announces Acquisition of a Gerber Collision Property for $3.5 Million
MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a Gerber Collision property for $3.5 million. The property is located in a highly trafficked corridor in North Carolina and corporate-operated under a triple net lease with approximately eight years of term r...
-
NUAI INVESTOR REMINDER: New Era Energy & Digital, Inc. Investors Have Until June 1, 2026 To Seek Lead Plaintiff Role - Contact Kirby McInerney LLP
NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ:NUAI) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until June 1, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after...
-
Audiencerate: Riccardo Fabbri treedt aan als Chief Technology Officer — De fase aangedreven door AI van de platformen voor kmo's en media-agentschappen vangt aan
LONDEN & MILAAN--(BUSINESS WIRE)--Audiencerate Ltd, een van de weinige wereldwijd gecertificeerde Google Customer Match Upload Partners en een Microsoft IP Co-sell-gecertificeerde partner die in aanmerking komt voor MACC, maakte vandaag de benoeming bekend van Riccardo Fabbri tot Chief Technology Officer. Dez benoeming markeert een fase van dubbele uitbreiding: het Audiencerate–Postel–Microsoft platform voor Italiaanse kmo's, en het Data platform geïntegreerd met Google DV360 voor agentschappen...
-
80% of Individual Contributors Say Their Manager’s Approach to AI is Hands-Off, FranklinCovey Research Finds
SALT LAKE CITY--(BUSINESS WIRE)--As organizations race to capture the benefits of artificial intelligence, research from FranklinCovey Institute reveals a critical obstacle: most employees feel they are navigating AI alone, without meaningful support or guidance. Eighty percent of individual contributors describe their manager’s approach to AI as “hands-off,” which underscores a widening gap between AI’s potential and how it’s actually used at work. FranklinCovey’s 2025 AI General Attitudes Sur...
-
Logitech Files Annual Report on Form 10-K
LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that it filed its Annual Report on Form 10-K for Fiscal Year 2026, which ended March 31, 2026, with the U.S. Securities and Exchange Commission. It is available on Logitech's website at http://ir.logitech.com. Logitech expects to publish its annual report to shareholders, and its invitation and proxy statemen...
-
Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a landmark oncology data program for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting will take place May 29–June 2 in Chicago, IL. Together with its collaborators, Natera will demonstrate unmatched scale in evidence generation with 35 abstracts across molecular residual disease (MRD) testing and other innovations. Presentations w...
-
Aulos Bioscience Reports Positive Phase 2 Data for Imneskibart in Doublet Checkpoint Inhibitor-Refractory Metastatic Melanoma at 2026 ASCO Annual Meeting
LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, a clinical-stage immuno-oncology company developing an immune-activating antibody therapeutic designed by leveraging an AI platform, today announced positive Phase 2 data from its ongoing Phase 1/2 study of imneskibart in patients with doublet checkpoint inhibitor (CPI)-refractory metastatic melanoma. The data will be presented in a poster session at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting in Chicago, Illinois. Th...